Synaptrix
Alpharetta, US · Founded 2022 · Delaware corporation · 1 known investors
Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief. The device is being evaluated in a US randomized controlled trial for perioperative pain management, aiming to reduce opioid use after surgeries such as knee replacement.
Founders & leadership
SS
Shyamy SastryExecutive
Board
DR
Doug ReedBoard director
RC
Robert CrutchfieldBoard director
AW
Anita WatkinsBoard director
KJ
Kurt JacobusBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2024
▶$10MraisedNov 2024 · 11 investors · Other TechnologyRule 506(b)
▶$10MraisedNov 2024 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Doug ReedDirector
- Shyamy SastryExecutive Officer, Director
- Kurt JacobusDirector
- Robert CrutchfieldExecutive Officer, Director
- Anita WatkinsDirector
- Offering amount
- $15M
- Amount sold
- $10M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Meduloc Medical Devices & Equipment3 shared keywordsMeduloc develops minimally invasive intramedullary implants for internal fixation of small and long-bone fractures. Its products are intended for orthopedic surgeons treating fracture patients in the medical device field.
Companies competing with Synaptrix for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Synaptrix do?
- Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief. The device is being evaluated in a US randomized controlled trial for perioperative pain management, aiming to reduce opioid use after surgeries such as knee replacement.
- Who are Synaptrix's investors?
- Synaptrix's investors include Hatteras Venture Partners.
- How much funding has Synaptrix raised?
- Synaptrix has disclosed $10M raised across 1 round.
- Where is Synaptrix headquartered?
- Synaptrix is headquartered in Alpharetta, US.